According to this latest study, the 2020 growth of Rare Disease Drug will have significant change from previous year. By the most conservative estimates of global Rare Disease Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Rare Disease Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Rare Disease Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Above 1‰

0.65‰～1‰

Below 0.1‰

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Hospital Pharmacies

Speciality Pharmacies

Retail pharmacies

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Novartis AG

Bristol-Myers Squibb Company

Celgene Corporation

F. Hoffmann-La Roche Ltd.

Pfizer, Inc.

Sanofi S.A.

Alexion Pharmaceuticals, Inc.

Eli Lilly and Company

Novo Nordisk A/S

AstraZeneca

Eisai Co., Ltd.

Daiichi Sankyo Company Limited

Bayer AG

GlaxoSmithKline

Merck & Co., Inc.

Johnson & Johnson

Biogen, Inc.

Takeda

Amgen, Inc.

Deciphera

Atara Biotherapeutics

ProQR

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Rare Disease Drug Consumption 2016-2026

2.1.2 Rare Disease Drug Consumption CAGR by Region

2.2 Rare Disease Drug Segment by Type

2.2.1 Above 1‰

2.2.2 0.65‰～1‰

2.2.3 Below 0.1‰

2.3 Rare Disease Drug Sales by Type

2.3.1 Global Rare Disease Drug Sales Market Share by Type (2016-2021)

2.3.2 Global Rare Disease Drug Revenue and Market Share by Type (2016-2021)

2.3.3 Global Rare Disease Drug Sale Price by Type (2016-2021)

2.4 Rare Disease Drug Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Speciality Pharmacies

2.4.3 Retail pharmacies

2.4.4 Others

2.5 Rare Disease Drug Sales by Application

2.5.1 Global Rare Disease Drug Sale Market Share by Application (2016-2021)

2.5.2 Global Rare Disease Drug Revenue and Market Share by Application (2016-2021)

2.5.3 Global Rare Disease Drug Sale Price by Application (2016-2021)

3 Global Rare Disease Drug by Company

3.1 Global Rare Disease Drug Sales Market Share by Company

3.1.1 Global Rare Disease Drug Sales by Company (2019-2021)

3.1.2 Global Rare Disease Drug Sales Market Share by Company (2019-2021)

3.2 Global Rare Disease Drug Revenue Market Share by Company

3.2.1 Global Rare Disease Drug Revenue by Company (2019-2021)

3.2.2 Global Rare Disease Drug Revenue Market Share by Company (2019-2021)

3.3 Global Rare Disease Drug Sale Price by Company

3.4 Global Manufacturers Rare Disease Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Rare Disease Drug Product Location Distribution

3.4.2 Players Rare Disease Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Rare Disease Drug by Region

4.1 Global Rare Disease Drug by Region

4.1.1 Global Rare Disease Drug Sales by Region

4.1.2 Global Rare Disease Drug Revenue by Region

4.2 Americas Rare Disease Drug Sales Growth

4.3 APAC Rare Disease Drug Sales Growth

4.4 Europe Rare Disease Drug Sales Growth

4.5 Middle East & Africa Rare Disease Drug Sales Growth

5 Americas

5.1 Americas Rare Disease Drug Sales by Country

5.1.1 Americas Rare Disease Drug Sales by Country (2016-2021)

5.1.2 Americas Rare Disease Drug Revenue by Country (2016-2021)

5.2 Americas Rare Disease Drug Sales by Type

5.3 Americas Rare Disease Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Rare Disease Drug Sales by Region

6.1.1 APAC Rare Disease Drug Sales by Region (2016-2021)

6.1.2 APAC Rare Disease Drug Revenue by Region (2016-2021)

6.2 APAC Rare Disease Drug Sales by Type

6.3 APAC Rare Disease Drug Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Rare Disease Drug by Country

7.1.1 Europe Rare Disease Drug Sales by Country (2016-2021)

7.1.2 Europe Rare Disease Drug Revenue by Country (2016-2021)

7.2 Europe Rare Disease Drug Sales by Type

7.3 Europe Rare Disease Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Rare Disease Drug by Country

8.1.1 Middle East & Africa Rare Disease Drug Sales by Country (2016-2021)

8.1.2 Middle East & Africa Rare Disease Drug Revenue by Country (2016-2021)

8.2 Middle East & Africa Rare Disease Drug Sales by Type

8.3 Middle East & Africa Rare Disease Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Rare Disease Drug Distributors

10.3 Rare Disease Drug Customer

11 Global Rare Disease Drug Market Forecast

11.1 Global Rare Disease Drug Forecast by Region

11.1.1 Global Rare Disease Drug Forecast by Regions (2021-2026)

11.2.2 Global Rare Disease Drug Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Rare Disease Drug Forecast by Type

11.7 Global Rare Disease Drug Forecast by Application

12 Key Players Analysis

12.1 Novartis AG

12.1.1 Novartis AG Novartis AG Company Information

12.1.2 Novartis AG Rare Disease Drug Product Offered

12.1.3 Novartis AG Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Novartis AG Main Business Overview

12.1.5 Novartis AG Latest Developments

12.2 Bristol-Myers Squibb Company

12.2.1 Bristol-Myers Squibb Company Company Information

12.2.2 Bristol-Myers Squibb Company Rare Disease Drug Product Offered

12.2.3 Bristol-Myers Squibb Company Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Bristol-Myers Squibb Company Main Business Overview

12.2.5 Bristol-Myers Squibb Company Latest Developments

12.3 Celgene Corporation

12.3.1 Celgene Corporation Company Information

12.3.2 Celgene Corporation Rare Disease Drug Product Offered

12.3.3 Celgene Corporation Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Celgene Corporation Main Business Overview

12.3.5 Celgene Corporation Latest Developments

12.4 F. Hoffmann-La Roche Ltd.

12.4.1 F. Hoffmann-La Roche Ltd. Company Information

12.4.2 F. Hoffmann-La Roche Ltd. Rare Disease Drug Product Offered

12.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 F. Hoffmann-La Roche Ltd. Main Business Overview

12.4.5 F. Hoffmann-La Roche Ltd. Latest Developments

12.5 Pfizer, Inc.

12.5.1 Pfizer, Inc. Company Information

12.5.2 Pfizer, Inc. Rare Disease Drug Product Offered

12.5.3 Pfizer, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Pfizer, Inc. Main Business Overview

12.5.5 Pfizer, Inc. Latest Developments

12.6 Sanofi S.A.

12.6.1 Sanofi S.A. Company Information

12.6.2 Sanofi S.A. Rare Disease Drug Product Offered

12.6.3 Sanofi S.A. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Sanofi S.A. Main Business Overview

12.6.5 Sanofi S.A. Latest Developments

12.7 Alexion Pharmaceuticals, Inc.

12.7.1 Alexion Pharmaceuticals, Inc. Company Information

12.7.2 Alexion Pharmaceuticals, Inc. Rare Disease Drug Product Offered

12.7.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Alexion Pharmaceuticals, Inc. Main Business Overview

12.7.5 Alexion Pharmaceuticals, Inc. Latest Developments

12.8 Eli Lilly and Company

12.8.1 Eli Lilly and Company Company Information

12.8.2 Eli Lilly and Company Rare Disease Drug Product Offered

12.8.3 Eli Lilly and Company Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Eli Lilly and Company Main Business Overview

12.8.5 Eli Lilly and Company Latest Developments

12.9 Novo Nordisk A/S

12.9.1 Novo Nordisk A/S Company Information

12.9.2 Novo Nordisk A/S Rare Disease Drug Product Offered

12.9.3 Novo Nordisk A/S Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Novo Nordisk A/S Main Business Overview

12.9.5 Novo Nordisk A/S Latest Developments

12.10 AstraZeneca

12.10.1 AstraZeneca Company Information

12.10.2 AstraZeneca Rare Disease Drug Product Offered

12.10.3 AstraZeneca Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 AstraZeneca Main Business Overview

12.10.5 AstraZeneca Latest Developments

12.11 Eisai Co., Ltd.

12.11.1 Eisai Co., Ltd. Company Information

12.11.2 Eisai Co., Ltd. Rare Disease Drug Product Offered

12.11.3 Eisai Co., Ltd. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Eisai Co., Ltd. Main Business Overview

12.11.5 Eisai Co., Ltd. Latest Developments

12.12 Daiichi Sankyo Company Limited

12.12.1 Daiichi Sankyo Company Limited Company Information

12.12.2 Daiichi Sankyo Company Limited Rare Disease Drug Product Offered

12.12.3 Daiichi Sankyo Company Limited Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Daiichi Sankyo Company Limited Main Business Overview

12.12.5 Daiichi Sankyo Company Limited Latest Developments

12.13 Bayer AG

12.13.1 Bayer AG Company Information

12.13.2 Bayer AG Rare Disease Drug Product Offered

12.13.3 Bayer AG Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Bayer AG Main Business Overview

12.13.5 Bayer AG Latest Developments

12.14 GlaxoSmithKline

12.14.1 GlaxoSmithKline Company Information

12.14.2 GlaxoSmithKline Rare Disease Drug Product Offered

12.14.3 GlaxoSmithKline Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 GlaxoSmithKline Main Business Overview

12.14.5 GlaxoSmithKline Latest Developments

12.15 Merck & Co., Inc.

12.15.1 Merck & Co., Inc. Company Information

12.15.2 Merck & Co., Inc. Rare Disease Drug Product Offered

12.15.3 Merck & Co., Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Merck & Co., Inc. Main Business Overview

12.15.5 Merck & Co., Inc. Latest Developments

12.16 Johnson & Johnson

12.16.1 Johnson & Johnson Company Information

12.16.2 Johnson & Johnson Rare Disease Drug Product Offered

12.16.3 Johnson & Johnson Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Johnson & Johnson Main Business Overview

12.16.5 Johnson & Johnson Latest Developments

12.17 Biogen, Inc.

12.17.1 Biogen, Inc. Company Information

12.17.2 Biogen, Inc. Rare Disease Drug Product Offered

12.17.3 Biogen, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Biogen, Inc. Main Business Overview

12.17.5 Biogen, Inc. Latest Developments

12.18 Takeda

12.18.1 Takeda Company Information

12.18.2 Takeda Rare Disease Drug Product Offered

12.18.3 Takeda Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 Takeda Main Business Overview

12.18.5 Takeda Latest Developments

12.19 Amgen, Inc.

12.19.1 Amgen, Inc. Company Information

12.19.2 Amgen, Inc. Rare Disease Drug Product Offered

12.19.3 Amgen, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.19.4 Amgen, Inc. Main Business Overview

12.19.5 Amgen, Inc. Latest Developments

12.20 Deciphera

12.20.1 Deciphera Company Information

12.20.2 Deciphera Rare Disease Drug Product Offered

12.20.3 Deciphera Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.20.4 Deciphera Main Business Overview

12.20.5 Deciphera Latest Developments

12.21 Atara Biotherapeutics

12.21.1 Atara Biotherapeutics Company Information

12.21.2 Atara Biotherapeutics Rare Disease Drug Product Offered

12.21.3 Atara Biotherapeutics Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.21.4 Atara Biotherapeutics Main Business Overview

12.21.5 Atara Biotherapeutics Latest Developments

12.22 ProQR

12.22.1 ProQR Company Information

12.22.2 ProQR Rare Disease Drug Product Offered

12.22.3 ProQR Rare Disease Drug Sales, Revenue, Price and Gross Margin (2019-2021)

12.22.4 ProQR Main Business Overview

12.22.5 ProQR Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Rare Disease Drug Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Above 1‰

Table 3. Major Players of 0.65‰～1‰

Table 4. Major Players of Below 0.1‰

Table 5. Global Rare Disease Drug Sales by Type (2016-2021) & (K Doses)

Table 6. Global Rare Disease Drug Sales Market Share by Type (2016-2021)

Table 7. Global Rare Disease Drug Revenue by Type (2016-2021) & ($ million)

Table 8. Global Rare Disease Drug Revenue Market Share by Type (2016-2021)

Table 9. Global Rare Disease Drug Sale Price by Type (2016-2021)

Table 10. Global Rare Disease Drug Sales by Application (2016-2021) & (K Doses)

Table 11. Global Rare Disease Drug Sales Market Share by Application (2016-2021)

Table 12. Global Rare Disease Drug Value by Application (2016-2021)

Table 13. Global Rare Disease Drug Revenue Market Share by Application (2016-2021)

Table 14. Global Rare Disease Drug Sale Price by Application (2016-2021)

Table 15. Global Rare Disease Drug Sales by Company (2019-2021) & (K Doses)

Table 16. Global Rare Disease Drug Sales Market Share by Company (2019-2021)

Table 17. Global Rare Disease Drug Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Rare Disease Drug Revenue Market Share by Company (2019-2021)

Table 19. Global Rare Disease Drug Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Rare Disease Drug Producing Area Distribution and Sales Area

Table 21. Players Rare Disease Drug Products Offered

Table 22. Rare Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Rare Disease Drug Sales by Region (2016-2021) (K Doses)

Table 26. Global Rare Disease Drug Sales Market Share by Region (2016-2021)

Table 27. Global Rare Disease Drug Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Rare Disease Drug Revenue Market Share by Region (2016-2021)

Table 29. Americas Rare Disease Drug Sales by Country (2016-2021) & (K Doses)

Table 30. Americas Rare Disease Drug Sales Market Share by Country (2016-2021)

Table 31. Americas Rare Disease Drug Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Rare Disease Drug Revenue Market Share by Country (2016-2021)

Table 33. Americas Rare Disease Drug Sales by Type (2016-2021) & (K Doses)

Table 34. Americas Rare Disease Drug Sales Market Share by Type (2016-2021)

Table 35. Americas Rare Disease Drug Sales by Application (2016-2021) & (K Doses)

Table 36. Americas Rare Disease Drug Sales Market Share by Application (2016-2021)

Table 37. APAC Rare Disease Drug Sales by Region (2016-2021) & (K Doses)

Table 38. APAC Rare Disease Drug Sales Market Share by Region (2016-2021)

Table 39. APAC Rare Disease Drug Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Rare Disease Drug Revenue Market Share by Region (2016-2021)

Table 41. APAC Rare Disease Drug Sales by Type (2016-2021) & (K Doses)

Table 42. APAC Rare Disease Drug Sales Market Share by Type (2016-2021)

Table 43. APAC Rare Disease Drug Sales by Application (2016-2021) & (K Doses)

Table 44. APAC Rare Disease Drug Sales Market Share by Application (2016-2021)

Table 45. Europe Rare Disease Drug Sales by Country (2016-2021) & (K Doses)

Table 46. Europe Rare Disease Drug Sales Market Share by Country (2016-2021)

Table 47. Europe Rare Disease Drug Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Rare Disease Drug Revenue Market Share by Country (2016-2021)

Table 49. Europe Rare Disease Drug Sales by Type (2016-2021) & (K Doses)

Table 50. Europe Rare Disease Drug Sales Market Share by Type (2016-2021)

Table 51. Europe Rare Disease Drug Sales by Application (2016-2021) & (K Doses)

Table 52. Europe Rare Disease Drug Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Rare Disease Drug Sales by Country (2016-2021) & (K Doses)

Table 54. Middle East & Africa Rare Disease Drug Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Rare Disease Drug Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Rare Disease Drug Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Rare Disease Drug Sales by Type (2016-2021) & (K Doses)

Table 58. Middle East & Africa Rare Disease Drug Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Rare Disease Drug Sales by Application (2016-2021) & (K Doses)

Table 60. Middle East & Africa Rare Disease Drug Sales Market Share by Application (2016-2021)

Table 61. Global Rare Disease Drug Sales Forecast by Type (2021-2026) & (K Doses)

Table 62. Global Rare Disease Drug Sales Market Share Forecast by Type (2021-2026)

Table 63. Global Rare Disease Drug Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 64. Global Rare Disease Drug Revenue Market Share Forecast by Type (2021-2026)

Table 65. Global Rare Disease Drug Sales Forecast by Application (2021-2026) & (K Doses)

Table 66. Global Rare Disease Drug Sales Market Share Forecast by Application (2021-2026)

Table 67. Global Rare Disease Drug Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 68. Global Rare Disease Drug Revenue Market Share Forecast by Application (2021-2026)

Table 69. Novartis AG Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 70. Novartis AG Rare Disease Drug Product Offered

Table 71. Novartis AG Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 72. Novartis AG Main Business

Table 73. Novartis AG Latest Developments

Table 74. Bristol-Myers Squibb Company Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 75. Bristol-Myers Squibb Company Rare Disease Drug Product Offered

Table 76. Bristol-Myers Squibb Company Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 77. Bristol-Myers Squibb Company Main Business

Table 78. Bristol-Myers Squibb Company Latest Developments

Table 79. Celgene Corporation Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 80. Celgene Corporation Rare Disease Drug Product Offered

Table 81. Celgene Corporation Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 82. Celgene Corporation Main Business

Table 83. Celgene Corporation Latest Developments

Table 84. F. Hoffmann-La Roche Ltd. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 85. F. Hoffmann-La Roche Ltd. Rare Disease Drug Product Offered

Table 86. F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 87. F. Hoffmann-La Roche Ltd. Main Business

Table 88. F. Hoffmann-La Roche Ltd. Latest Developments

Table 89. Pfizer, Inc. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 90. Pfizer, Inc. Rare Disease Drug Product Offered

Table 91. Pfizer, Inc. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 92. Pfizer, Inc. Main Business

Table 93. Pfizer, Inc. Latest Developments

Table 94. Sanofi S.A. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Sanofi S.A. Rare Disease Drug Product Offered

Table 96. Sanofi S.A. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 97. Sanofi S.A. Main Business

Table 98. Sanofi S.A. Latest Developments

Table 99. Alexion Pharmaceuticals, Inc. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Alexion Pharmaceuticals, Inc. Rare Disease Drug Product Offered

Table 101. Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 102. Alexion Pharmaceuticals, Inc. Main Business

Table 103. Alexion Pharmaceuticals, Inc. Latest Developments

Table 104. Eli Lilly and Company Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Eli Lilly and Company Rare Disease Drug Product Offered

Table 106. Eli Lilly and Company Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 107. Eli Lilly and Company Main Business

Table 108. Eli Lilly and Company Latest Developments

Table 109. Novo Nordisk A/S Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Novo Nordisk A/S Rare Disease Drug Product Offered

Table 111. Novo Nordisk A/S Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 112. Novo Nordisk A/S Main Business

Table 113. Novo Nordisk A/S Latest Developments

Table 114. AstraZeneca Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. AstraZeneca Rare Disease Drug Product Offered

Table 116. AstraZeneca Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 117. AstraZeneca Main Business

Table 118. AstraZeneca Latest Developments

Table 119. Eisai Co., Ltd. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Eisai Co., Ltd. Rare Disease Drug Product Offered

Table 121. Eisai Co., Ltd. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 122. Eisai Co., Ltd. Main Business

Table 123. Eisai Co., Ltd. Latest Developments

Table 124. Daiichi Sankyo Company Limited Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Daiichi Sankyo Company Limited Rare Disease Drug Product Offered

Table 126. Daiichi Sankyo Company Limited Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 127. Daiichi Sankyo Company Limited Main Business

Table 128. Daiichi Sankyo Company Limited Latest Developments

Table 129. Bayer AG Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. Bayer AG Rare Disease Drug Product Offered

Table 131. Bayer AG Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 132. Bayer AG Main Business

Table 133. Bayer AG Latest Developments

Table 134. GlaxoSmithKline Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. GlaxoSmithKline Rare Disease Drug Product Offered

Table 136. GlaxoSmithKline Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 137. GlaxoSmithKline Main Business

Table 138. GlaxoSmithKline Latest Developments

Table 139. Merck & Co., Inc. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Merck & Co., Inc. Rare Disease Drug Product Offered

Table 141. Merck & Co., Inc. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 142. Merck & Co., Inc. Main Business

Table 143. Merck & Co., Inc. Latest Developments

Table 144. Johnson & Johnson Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 145. Johnson & Johnson Rare Disease Drug Product Offered

Table 146. Johnson & Johnson Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 147. Johnson & Johnson Main Business

Table 148. Johnson & Johnson Latest Developments

Table 149. Biogen, Inc. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 150. Biogen, Inc. Rare Disease Drug Product Offered

Table 151. Biogen, Inc. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 152. Biogen, Inc. Main Business

Table 153. Biogen, Inc. Latest Developments

Table 154. Takeda Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 155. Takeda Rare Disease Drug Product Offered

Table 156. Takeda Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 157. Takeda Main Business

Table 158. Takeda Latest Developments

Table 159. Amgen, Inc. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 160. Amgen, Inc. Rare Disease Drug Product Offered

Table 161. Amgen, Inc. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 162. Amgen, Inc. Main Business

Table 163. Amgen, Inc. Latest Developments

Table 164. Deciphera Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 165. Deciphera Rare Disease Drug Product Offered

Table 166. Deciphera Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 167. Deciphera Main Business

Table 168. Deciphera Latest Developments

Table 169. Atara Biotherapeutics Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 170. Atara Biotherapeutics Rare Disease Drug Product Offered

Table 171. Atara Biotherapeutics Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 172. Atara Biotherapeutics Main Business

Table 173. Atara Biotherapeutics Latest Developments

Table 174. ProQR Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 175. ProQR Rare Disease Drug Product Offered

Table 176. ProQR Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 177. ProQR Main Business

Table 178. ProQR Latest Developments

List of Figures

Figure 1. Picture of Rare Disease Drug

Figure 2. Rare Disease Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Rare Disease Drug Sales Growth Rate 2016-2026 (K Doses)

Figure 7. Global Rare Disease Drug Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Rare Disease Drug Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Above 1‰

Figure 10. Product Picture of 0.65‰～1‰

Figure 11. Product Picture of Below 0.1‰

Figure 12. Global Rare Disease Drug Sales Market Share by Type in 2020

Figure 13. Global Rare Disease Drug Revenue Market Share by Type (2016-2021)

Figure 14. Rare Disease Drug Consumed in Hospital Pharmacies

Figure 15. Global Rare Disease Drug Market: Hospital Pharmacies (2016-2021) & (K Doses)

Figure 16. Rare Disease Drug Consumed in Speciality Pharmacies

Figure 17. Global Rare Disease Drug Market: Speciality Pharmacies (2016-2021) & (K Doses)

Figure 18. Rare Disease Drug Consumed in Retail pharmacies

Figure 19. Global Rare Disease Drug Market: Retail pharmacies (2016-2021) & (K Doses)

Figure 20. Rare Disease Drug Consumed in Others

Figure 21. Global Rare Disease Drug Market: Others (2016-2021) & (K Doses)

Figure 22. Global Rare Disease Drug Sales Market Share by Application (2016-2021)

Figure 23. Global Rare Disease Drug Revenue Market Share by Application in 2020

Figure 24. Global Rare Disease Drug Revenue Market by Company in 2020 ($ Million)

Figure 25. Global Rare Disease Drug Revenue Market Share by Company in 2020

Figure 26. Global Rare Disease Drug Sales Market Share by Regions (2016-2021)

Figure 27. Global Rare Disease Drug Revenue Market Share by Region in 2020

Figure 28. Americas Rare Disease Drug Sales 2016-2021 (K Doses)

Figure 29. Americas Rare Disease Drug Revenue 2016-2021 ($ Millions)

Figure 30. APAC Rare Disease Drug Sales 2016-2021 (K Doses)

Figure 31. APAC Rare Disease Drug Revenue 2016-2021 ($ Millions)

Figure 32. Europe Rare Disease Drug Sales 2016-2021 (K Doses)

Figure 33. Europe Rare Disease Drug Revenue 2016-2021 ($ Millions)

Figure 34. Middle East & Africa Rare Disease Drug Sales 2016-2021 (K Doses)

Figure 35. Middle East & Africa Rare Disease Drug Revenue 2016-2021 ($ Millions)

Figure 36. Americas Rare Disease Drug Sales Market Share by Country in 2020

Figure 37. Americas Rare Disease Drug Revenue Market Share by Country in 2020

Figure 38. Americas Rare Disease Drug Sales Market Share by Type in 2020

Figure 39. Americas Rare Disease Drug Sales Market Share by Application in 2020

Figure 40. United States Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 41. Canada Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 42. Mexico Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 43. Brazil Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 44. APAC Rare Disease Drug Sales Market Share by Region in 2020

Figure 45. APAC Rare Disease Drug Revenue Market Share by Regions in 2020

Figure 46. APAC Rare Disease Drug Sales Market Share by Type in 2020

Figure 47. APAC Rare Disease Drug Sales Market Share by Application in 2020

Figure 48. China Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 49. Japan Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 50. Korea Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 51. Southeast Asia Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 52. India Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 53. Australia Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 54. Europe Rare Disease Drug Sales Market Share by Country in 2020

Figure 55. Europe Rare Disease Drug Revenue Market Share by Country in 2020

Figure 56. Europe Rare Disease Drug Sales Market Share by Type in 2020

Figure 57. Europe Rare Disease Drug Sales Market Share by Application in 2020

Figure 58. Germany Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 59. France Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 60. UK Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 61. Italy Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 62. Russia Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 63. Middle East & Africa Rare Disease Drug Sales Market Share by Country in 2020

Figure 64. Middle East & Africa Rare Disease Drug Revenue Market Share by Country in 2020

Figure 65. Middle East & Africa Rare Disease Drug Sales Market Share by Type in 2020

Figure 66. Middle East & Africa Rare Disease Drug Sales Market Share by Application in 2020

Figure 67. Egypt Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 68. South Africa Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 69. Israel Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 70. Turkey Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 71. GCC Country Rare Disease Drug Revenue Growth 2016-2021 ($ Millions)

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles